Rohto Pharmaceutical Co.,Ltd. (FRA:UC1)
Germany · Delayed Price · Currency is EUR 13.80
+0.20 (1.47%)
At close: Jan 30, 2026
Rohto Pharmaceutical Market Cap
Rohto Pharmaceutical has a market cap or net worth of €3.15 billion as of January 30, 2026. Its market cap has decreased by -21.63% in one year.
Market Cap
3.15B
Enterprise Value
3.08B
Revenue
1.92B
Ranking
n/a
PE Ratio
15.32
Stock Price
€13.80
Market Cap Chart
Since July 4, 1997, Rohto Pharmaceutical's market cap has increased from 507.72M to 3.15B, an increase of 520.91%. That is a compound annual growth rate of 6.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 3.15B | -2.41% |
| Dec 30, 2025 | 3.23B | -19.76% |
| Dec 30, 2024 | 4.03B | -3.29% |
| Dec 29, 2023 | 4.16B | 10.84% |
| Dec 30, 2022 | 3.76B | 23.51% |
| Dec 30, 2021 | 3.04B | 10.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |